Standardized Treatment of Pulmonary Exacerbations II

PHASE4CompletedINTERVENTIONAL
Enrollment

982

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 6, 2020

Study Completion Date

March 6, 2020

Conditions
Pulmonary Cystic Fibrosis
Interventions
DRUG

Standard of care IV antibiotic(s)

IV antibiotics will be selected by the treating physician following standard of care. Duration of treatment is the assigned intervention.

Trial Locations (58)

10003

Beth Israel Medical Center, New York

10032

Columbia University Medical Center, New York

10595

New York Medical College, Valhalla

11040

The Long Island Jewish Medical Center, New Hyde Park

13210

SUNY Upstate Medical University Hospital, Syracuse

14222

Women and Children's Hospital of Buffalo, Buffalo

14642

Highland Hospital; Strong Memorial Hospital, Rochester

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

17033

Penn State Milton S. Hershey Medical Center, Hershey

19104

Hospital of the University of Pennsylvania, Philadelphia

21205

John Hopkins Hospital, Baltimore

22908

University of Virginia Health System, Charlottesville

23298

Medical College of Virginia (Richmond, VA), Richmond

26506

Ruby Memorial Hospital, Morgantown

27157

Wake Forest University Baptist Medical Center, Winston-Salem

27517

North Carolina Children's Hospital, Chapel Hill

29425

Medical University of South Carolina; Medical University of South Carolina Children's Hospital, Charleston

30322

Emory University Hospital, Atlanta

30912

Augusta University Medical Center, Augusta

32610

Shands Hospital, Gainesville

33021

Joe DiMaggio Children's Hospital (Adult), Hollywood

33136

University of Miami, Miami

35233

The Children's Hospital Alabama, Birmingham

43205

Nationwide Children's Hospital, Columbus

44106

University Hospital of Cleveland, Cleveland

44308

Akron Children's Hospital, Akron

45404

Dayton Children's Hospital, Dayton

46202

Indiana University Hospital, Indiana University Health, Indianapolis

48201

Detroit Medical Center; Harper University Hospital, Detroit

53226

Froedtert Hospital, Milwaukee

53792

University of Wisconsin Hospital Center, Madison

61603

Saint Francis Medical Center, Peoria

63110

Saint Louis University Hospital, St Louis

St. Louis Washington University Adult - Barnes-Jewish Hospital, St Louis

66160

The University of Kansas Hospital, Kansas City

75390

University of Texas Southwestern, Dallas

77030

Baylor St. Lukes Medical Center, Houston

80206

National Jewish Health, Denver

83712

St. Luke's Regional Medical Center, Boise

85724

University Medical Center, Tucson

92037

UC San Diego Medical Center, La Jolla

94304

Lucile S. Packard Children's Hospital, Palo Alto

95817

University of California Davis, Health System, Sacramento

98195

University of Washington Medical Center, Seattle

99519-6604

Providence Alaska Medical Center, Anchorage

06106

Hartford Hospital, Hartford

06520

Yale New Haven Hospital, New Haven

02115

Boston Children's Hospital (BCH), Boston

01655

University of Massachusetts Memorial Health Care (Worcester, MA), Worcester

48109-5212

University of Michigan Health System, Ann Arbor

59107-7000

Billings Clinic, Billings

03756

Dartmouth Hitchcock Medical Center, Lebanon

07740

Monmouth Medical Center, Long Branch

07960

Morristown Medical Center, Morristown

08903

Robert Wood Johnson University Hospital (New Brunswick, NJ), New Brunswick

75708-3154

University of Texas Health Center at Tyler, Tyler

05401

The University of Vermont Medical Center Inc., Burlington

T2N 4N1

Calgary Canada Adult CF Clinic, Calgary

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

collaborator

CF Therapeutics Development Network Coordinating Center

NETWORK

collaborator

Medical University of South Carolina

OTHER

collaborator

University of Washington

OTHER

lead

Chris Goss

OTHER

NCT02781610 - Standardized Treatment of Pulmonary Exacerbations II | Biotech Hunter | Biotech Hunter